President, Paul Ehrlich Institute
Klaus Cichutek is President of the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Germany, and extra-ordinary Professor of Biochemistry at the Goethe University Frankfurt/Main.
The Paul-Ehrlich-Institut is a research and science driven Medicines Agency (veterinary and human vaccines, human biomedicines) reporting to the German Federal Ministry of Health and providing regulatory services to the European Medicines Agency EMA, EDQM, WHO and others.
1976 to 1984 - studies of and Ph.D. in biochemistry
1985 to 1988 - postdoctoral scientist at the Molecular Biology and Virus Laboratory, University of California in Berkeley, U.S.A., on fellowships of the DFG (German Research Foundation) and the Univ. of California
1988 to 1994 - head, 'Molecular Biology' Research Group, Paul-Ehrlich-Institut, Langen
1994 to 2011 - head, Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen
1999 to 2009 - Vice President, Paul-Ehrlich-Institut, Langen
2009 to 2023 - President, Paul-Ehrlich-Institut, Langen
Research interests: Retrovirology and gene therapy (> 150 publications).
- Biomedical medicinal products including advanced therapy medicinal products and DNA/vector vaccine
- Gene therapy (e.g. cell targeting retroviral vectors, stem cell gene transfer)
- Retrovirology with a focus on pseudotyping, HIV/SIV immunopathogenesis and AIDS
Prof. Cichutek is the author of over 150 scientific publications.
Committee and board memberships (selection):
- CHMP "Gene Therapy Working Party" (GTWP), European Medicines Agency (EMA) (chair; 2003-2010)
- "ICH Gene Therapy Discussion Group" of the "International Conference on Harmonization of Pharmaceutical Requirements…" (co-chair; 2004-2010)
- Board of the “European Society of Gene and Cell Therapy" (ESGCT) (member; 2005 – 2010)
- European "Heads of Medicines Agencies" (HMA Management Group chair; 02/2014 to 02/2018),
- "WHO Expert Committee on Biological Standardization" (ECBS) (elected chair in 2016/17/18/19/20),
- "Product Development for Vaccines Advisory Committee (PD-VAC)" (WHO, member; 2012-2021)
- ICMRA (“International Coalition of Medicines Regulatory Authorities") (member; 2012 – 2023),
- "German Center for Infection Research" DZIF (founding member; 2012 – today),
- reviewer of research proposals for the Federal Ministry of Education and Research, the German Research Foundation DFG, Fraunhofer, Helmholtz Association, the European Commission and of scientific publications for a variety of scientific journals.